Stock UniverseDerived research view · source repositories remain read-only

Viatris Inc. (VTRS)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Qualified
Selection Score
35.84
Global Rank
1121
Market Cap
17.19B
Latest Close
15.88
RS Composite
13.37% · G#625

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
0.29%
3M
13.94%
6M
48.83%
1Y
92.15%
3Y
97.52%
5Y
28.59%
10Y
-54.46%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 8.98M · 30-day average: 12.32M · Max drawdown over stored range: -82.86%

Research Snapshot

Relative Strength vs SPX

RS Composite13.37%
20D RS-8.65%
60D RS5.53%
120D RS32.21%
Global RS Rank625 · 81.37% percentile
Qualified+ RS Rank243 · 80.68% percentile
Group ScopeQualified+
Primary RS Rank82 · 82.10% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank183 / 701
Primary Percentile74.04
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0714.52B5.01B139.40Mn/an/a3.46B514.20M2.95B1,203M34.51%0.96%n/a23.83%20.29%1.80B12.41B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31n/an/a$12.071.3x$2.456.5x$2.885.5x

Shares Diluted: 1,203M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1194617886.316262.715426.914739.314299.9
Revenue Growth (YoY)3.874%49.726%-9.077%-5.139%-4.457%-2.981%
Gross Profit4555.46011.36925.76732.36138.45655.2
Operating Income1361.11098.32746.92154.31774.71233.8
Free Cash Flow988.82559.7259325231976.91937.1
Free Cash Flow Per Share1.6452.1182.132.091.6571.655
EPS (Diluted) GAAP-1.114271-1.051.710.045571-0.531467-3.002391
EPS Growth10300%10300%10300%-97.335%10300%
EPS Non-GAAP
Gross Margin38.133%33.608%42.586%43.64%41.646%39.547%
Operating Margin11.394%6.14%16.891%13.965%12.041%8.628%
Profit Margin-5.608%-7.095%12.781%0.355%-4.303%-24.58%
Free Cash Flow Margin8.277%14.311%15.944%16.355%13.412%13.546%
Shares Outstanding (Diluted)601.21208.81217.41206.91193.31170.7
Shares Change (YoY)16.399%101.065%0.711%-0.862%-1.127%-1.894%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-073.51B32.97%-79.70M-2.27%n/an/a0.151.18B1.80B12.41Bprocessed
2025 Q42026-02-263.69B31.10%-192.70M-5.22%n/an/an/a1.30B1.32B12.48Bprocessed
2025 Q32025-11-063.75B36.60%178.80M4.77%n/an/a-0.111.16B975.30M12.49Bprocessed
2025 Q22025-08-073.57B37.35%233.00M6.53%n/an/a-0.271.17B566.40M12.79Bprocessed
2025 Q12025-05-083.24B35.80%-2.88B-88.87%n/an/a-2.551.19B755.00M14.18Bprocessed
2024 Q42025-02-273.52B34.56%-179.80M-5.11%n/an/an/a1.29B734.80M14.04Bprocessed
2024 Q32024-11-073.74B39.04%225.90M6.04%n/an/a0.081.20B1.88B14.30Bprocessed
2024 Q22024-08-083.79B38.18%-239.90M-6.34%n/an/a-0.271.19B917.20M14.73Bprocessed
2024 Q12024-05-093.65B41.17%203.90M5.58%n/an/a0.091.21B1.01B16.07Bprocessed
2023 Q42024-02-283.83B41.73%-454.50M-11.88%n/an/an/a1.19B991.90M16.19Bprocessed
2023 Q32023-11-083.93B42.99%451.70M11.48%n/an/a0.271.22B1.31B17.08Bprocessed
2023 Q22023-08-073.91B41.15%369.20M9.44%n/an/a0.221.22B629.20M17.27Bprocessed
2023 Q12023-05-083.72B41.47%399.80M10.75%n/an/a0.191.21B506.60M18.27Bprocessed
2022 Q42023-02-273.87B32.95%-201.30M-5.21%n/an/an/a1.22B1.26B19.51Bprocessed
2022 Q32022-11-074.07B42.99%560.10M13.77%n/an/a0.291.22B646.70M19.22Bprocessed
2022 Q22022-08-084.11B41.49%548.70M13.37%n/an/a0.261.22B664.70M20.23Bprocessed
2022 Q12022-05-094.18B42.39%707.40M16.93%n/an/a0.331.21B752.40M19.42Bprocessed
2021 Q42022-02-284.33B35.70%-77.60M-1.79%n/an/an/a1.21B701.20M21.21Bprocessed
2021 Q32021-11-084.52B34.82%357.60M7.91%n/an/a0.261.21B756.60M21.56Bprocessed
2021 Q22021-08-094.56B29.11%-47.80M-1.05%n/an/a-0.231.21B673.90M22.22Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.